BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16465428)

  • 1. Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival.
    Takashima N; Ishiguro H; Kuwabara Y; Kimura M; Haruki N; Ando T; Kurehara H; Sugito N; Mori R; Fujii Y
    Oncol Rep; 2006 Mar; 15(3):667-71. PubMed ID: 16465428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.
    Terashita Y; Ishiguro H; Haruki N; Sugiura H; Tanaka T; Kimura M; Shinoda N; Kuwabara Y; Fujii Y
    Oncol Rep; 2004 Oct; 12(4):827-31. PubMed ID: 15375507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.
    Kurehara H; Ishiguro H; Kimura M; Mitsui A; Ando T; Sugito N; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
    Int J Oncol; 2007 Feb; 30(2):421-8. PubMed ID: 17203224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
    Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of detecting mucin 1 mRNA in diagnosing occult lymph node micrometastasis in esophageal cancer patients.
    Liu XY; Chen G; Wang Z; Liu FY
    Ai Zheng; 2007 Feb; 26(2):194-9. PubMed ID: 17298752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
    Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
    Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma.
    Wada S; Noguchi T; Takeno S; Kawahara K
    Ann Surg Oncol; 2006 Jul; 13(7):961-6. PubMed ID: 16788758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
    Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M
    Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene.
    Barclay C; Li AW; Geldenhuys L; Baguma-Nibasheka M; Porter GA; Veugelers PJ; Murphy PR; Casson AG
    Clin Cancer Res; 2005 Nov; 11(21):7683-91. PubMed ID: 16278388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.
    Yamagata M; Mori M; Mimori K; Mafune KI; Tanaka Y; Ueo H; Akiyoshi T
    Br J Cancer; 1999 Feb; 79(3-4):565-9. PubMed ID: 10027331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
    Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma.
    Gu ZD; Shen LY; Wang H; Chen XM; Li Y; Ning T; Chen KN
    Cancer Res; 2009 Jun; 69(12):4969-73. PubMed ID: 19491265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.